Pseudomonas aeruginosa immunotype 5 polysaccharide-toxin A conjugate vaccine

Infect Immun. 1986 Apr;52(1):161-5. doi: 10.1128/iai.52.1.161-165.1986.

Abstract

Polysaccharide (PS) derived from Pseudomonas aeruginosa immunotype 5 lipopolysaccharide was covalently coupled to toxin A by reductive amination with adipic acid dihydrazide as a spacer molecule. The resulting PS-toxin A conjugate was composed of 27.5% PS and 72.5% toxin A. The conjugate was composed of heterogeneous high-molecular-weight species, all of which possessed an Mr greater than 670,000. The conjugate was nontoxic for mice and nonpyrogenic at a dose of 50 micrograms/kg of body weight when intravenously administered to rabbits. Immunization of rabbits with the conjugate evoked both an antilipopolysaccharide immunoglobulin G (IgG) and an anti-toxin A IgG response. Anticonjugate IgG was capable of neutralizing the cytotoxic effect of toxin A. Immunization of mice with the conjugate increased the mean lethal dose from 4.5 X 10(1) P. aeruginosa for control mice to 9.6 X 10(5) P. aeruginosa for vaccinated mice. Similarly, immunization raised the mean lethal dose for toxin A from 0.2 to 4.67 micrograms per mouse.

MeSH terms

  • Animals
  • Bacterial Vaccines / immunology*
  • Burns / immunology
  • Lipopolysaccharides / immunology
  • Mice
  • Polysaccharides, Bacterial / immunology*
  • Pseudomonas Infections / prevention & control
  • Pseudomonas aeruginosa / immunology*

Substances

  • Bacterial Vaccines
  • Lipopolysaccharides
  • Polysaccharides, Bacterial